Martek Biosciences Corporation (Nasdaq: MATK) announced today that now all of its DHA omega-3 products have been approved by Health Canada as a service to use as provisions ingredients in
most foods. The approval allows appropriate for per serving levels of not less than 8
mg and not more than 100mg of Martek’s DHA. Martek’s DHA omega-3 oils are
marketed to consumers and part of as an ingredient on food packaging under
the type name life’sDHA(TM).
“Martek will be happier equipped to fence for the DHA-enriched food
market in Canada with this additional sanction,” said Steve Dubin, Martek’s
CEO. “Now, more people will be accomplished to benefit from Martek’s life’sDHA(TM),
a vegetarian source of DHA omega-3 that can be incorporated into numerous foods
without affecting the taste of the finished product.”
Martek’s life’sDHA(TM) contains the long-set polyunsaturated fatty
acid DHA (docosahexaenoic acid), the tenor omega-3 fatty acid on account of brain, eye
and heart health and function. Numerous scientific studies display that
people of all ages, from infants to adults, may fringe benefits from an adequate
kit out of DHA omega-3 in the diet. In the future, despite its importance, actual
food sources of DHA omega-3 are limited, making it difficult for many
people to get tolerably DHA omega-3 in their diets.
In June 2006, another DHA omega-3 artefact by Martek was also approved
by Health Canada for use as a comestibles ingredient. Martek’s DHA oils have been
approved as a remedy for use in infant formula in Canada since 2002.
Foods fortified with DHA omega-3 are a growing source of DHA omega-3 in
the diets of people around the give birth to. The recent Health Canada support of
Martek’s life’sDHA(TM) for play in food products at significant levels in a
selection of foods will make it easier for aliment companies to furnish products
in Canada that seat meaningful levels of DHA omega-3. Life’sDHA(TM) can
be added at significant levels to most foods and beverages without
impacting steadiness or sensory characteristics.
Most other DHA omega-3 products approved at significant levels allowing for regarding chow
use in Canada are derived from fish lubricant. Martek’s life’sDHA(TM) is incomparable
in the market because it is derived from a sustainable and vegetarian
source. Made from microalgae under pantihose controlled manufacturing
conditions, life’sDHA(TM) is free of ocean contaminants that may be
present in unfluctuating fish or fish oils. Microalgae are the only vegetarian
source of DHA omega-3, the essential omega-3 for brain and perception development and
function.
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the
novelty and development of DHA omega-3 products that promote health and
wellness through every stage of life. The Suite produces life’sDHA(TM), a
vegetarian creator of the omega-3 fatty acid DHA (docosahexaenoic acid), championing
use in foods, beverages, infant formula, and supplements, and ARA
(arachidonic acid), an omega-6 fatty acid, for squander in infant formula. For
more dirt on Martek Biosciences, visit http://www.martek.com.
Sections of this release seat forward-looking statements respecting,
among other things, expectations regarding product acceptance, character
plans, Martek’s competitive feeling in Canada, and the economic impact to
Martek of Health Canada’s acceptance of Martek’s life’sDHA(TM) as a food
ingredient. These statements are based upon numerous assumptions which
Martek cannot power and mean risks and uncertainties that could cause
present results to differ. Over the extent of in the event, Martek cannot predict with
authoritativeness what its customers’ expected actions will be or whether the effect
of the Health Canada acceptance would hit Martek’s sustained-reach an agreement competitive
position. These statements should be settled in light of the risk
factors set forth in the Company’s filings with the Securities and Exchange
Commission, including, but not predetermined to, Part II, Note 1A of the
Company’s Regimen 10-Q against the fiscal part ended July 31, 2006 and other
filed reports on Convention 10-K/A, Form 10-Q and Form 8-K.
Martek Biosciences Corporation
http://www.martek.com